awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33562198-123331B9-C291-4E0A-A5C2-CCEB9D5B2310
Q33562198-123331B9-C291-4E0A-A5C2-CCEB9D5B2310
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33562198-123331B9-C291-4E0A-A5C2-CCEB9D5B2310
Catastrophic outcome of patients with a rebound after Natalizumab treatment discontinuation
P2860
Q33562198-123331B9-C291-4E0A-A5C2-CCEB9D5B2310
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33562198-123331B9-C291-4E0A-A5C2-CCEB9D5B2310
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c23e34583691468ed210de2145dde405195794bd
P2860
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis